Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 13 Aug 2025 for ABIVAX, €16.7M. Read the official filing
Filing timeline
BuySaleAris Constantinides
Insider track record
Disclosed buys
0
Disclosed sells
1
Signal history
Aris Constantinides: trading record in brief
Aris Constantinides (board member) discloses dealings in Abivax to AMF. Activity is concentrated on a single trading day, 6 August 2025, with 2 filings.
The open-market record consists of 1 sale worth €59.7M, with no purchase. Other entries cover 1 option exercise.
The latest filing, published on 13 August 2025, reports an option exercise of €16.7M in Abivax. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from AMF disclosures alone and does not predict where the share price will go.
Companies and markets linked to Aris Constantinides
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
1,104,640 shares@ €15.087921.8% of flowActionEuronext ParisISIN FR00123332842025DD1053421
1,104,640 shares@ €54.0078.2% of flowActionEuronext ParisISIN FR00123332842025DD1053431
2 of 2 declarations
